TCM
GHDX

Tekla Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Tekla Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,531
Closed -$1.54M – 209
2019
Q2 		$1.54M Hold
26,531
– – 0.06% 143
2019
Q1 		$1.86M Buy
26,531
+9,161
+53% +$679K 0.08% 135
2018
Q4 		$1.12M Sell
17,370
-17,370
-50% -$1.22M 0.05% 161
2018
Q3 		$2.44M Buy
+34,740
New +$2.03M 0.09% 139

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Tekla Capital Management's GHDX Position: Q3 2019 in Review

Tekla Capital Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 26,531 shares — an estimated $1.54M sold.

Tekla Capital Management first reported a position in GHDX in Q3 2018 and held it in 4 quarters. The position peaked at $2.44M in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Tekla Capital Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Tekla Capital Management sold 26,531 Genomic Health, Inc. shares in Q3 2019, an estimated $1.54M.
  • Tekla Capital Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 4 quarters.
  • Tekla Capital Management's Genomic Health, Inc. position peaked at $2.44M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Tekla Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.